All changes for the tissue bone marrow (47)

Identifier Name Type Tissues Organism Gene Data Actions
DAA2035 Alterations in frequency, developmental potential and gene expression profile in hematopoietic stem cells Physiological hematopoietic stem cells Human
DAA2443 AMP-activated protein kinase; non-catalytic gamma-3 subunit decreases with age Molecular mesenchymal stem cell Human PRKAG3 15.1% Decrease DNA Methylation
DAA2444 AMP-activated protein kinase; non-catalytic gamma-3 subunit decreases with age Molecular mesenchymal stem cell Human PRKAG3 20.1% Decrease DNA Methylation
DAA2442 ATP-binding cassette; sub-family A member 8 decreases with age Molecular mesenchymal stem cell Human ABCA8 25.0% Decrease DNA Methylation
DAA675 Beta-galactosidase expression increases in mesenchymal stem cells Physiological mesenchymal stem cell Human
DAA2461 calcyphosine isoform b decreases with age Molecular mesenchymal stem cell Human CAPS 17.3% Decrease DNA Methylation
DAA678 Capacity of mesenchymal stem cells to differentiate into osteoblasts may be decreased Physiological mesenchymal stem cell Human
DAA2450 casein kappa increases with age Molecular mesenchymal stem cell Human CSN3 16.3% Increase DNA Methylation
DAA2455 CD34 antigen isoform b decreases with age Molecular mesenchymal stem cell Human CD34 17.3% Decrease DNA Methylation
DAA2454 chemokine (C-C motif) receptor 1 increases with age Molecular mesenchymal stem cell Human CCR1 31.2% Increase DNA Methylation
DAA2441 complement factor D preproprotein increases with age Molecular mesenchymal stem cell Human CFD 22.2% Increase DNA Methylation
DAA2433 cyclin-dependent kinase inhibitor 2B isoform 2 decreases with age Molecular mesenchymal stem cell Human CDKN2B 16.7% Decrease DNA Methylation
DAA2437 dehydrogenase/reductase (SDR family) member 3 decreases with age Molecular mesenchymal stem cell Human DHRS3 18.6% Decrease DNA Methylation
DAA2027 DNA damage acummulates in hematopoietic stem and progenitor cells Physiological hematopoietic stem cells Human
DAA1073 Fewer cells and higher apoptosis Physiological bone marrow Human
DAA2460 gelsolin-like capping protein decreases with age Molecular mesenchymal stem cell Human CAPG 19.3% Decrease DNA Methylation
DAA1991 Hematopoietic cells accumulate random mutations Physiological hematopoietic stem cells Human
DAA2452 homeo box B1 decreases with age Molecular mesenchymal stem cell Human HOXB1 49.3% Decrease DNA Methylation
DAA2453 hypothetical protein LOC126353 decreases with age Molecular mesenchymal stem cell Human MISP 24.8% Decrease DNA Methylation
DAA2458 hypothetical protein LOC146433 decreases with age Molecular mesenchymal stem cell Human IL34 27.7% Decrease DNA Methylation
DAA2439 hypothetical protein LOC283598 increases with age Molecular mesenchymal stem cell Human C14orf177 42.5% Increase DNA Methylation
DAA2463 Level of miR-19a decreases with age Molecular mesenchymal stem cell Human MIR19A 40.7% Decrease miRNA Level
DAA2462 Level of miR-519d decreases with age Molecular mesenchymal stem cell Human MIR519D 44.7% Decrease miRNA Level
DAA2445 L-pipecolic acid oxidase increases with age Molecular mesenchymal stem cell Human PIPOX 32.2% Increase DNA Methylation
DAA2449 microfibrillar associated protein 5 decreases with age Molecular mesenchymal stem cell Human MFAP5 46.4% Decrease DNA Methylation